BGNE's logo.
Ticker Symbol: BGNE

BeiGene Ltd - ADR

$389.34 - 07-10-2024 4 p.m. ET

Exchange: NASDAQ Country: China (Mainland) Currency: USD Asset Type: ADR CIK:0001651308

Company Profile

BeiGene is a biotechnology company that specializes in the development of drugs for cancer treatment. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: No. 30 Science Park Road
CEO: John Oyler
Tags:
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $165.21
Change: $6.54 ( 4.12%)
Days Range: $156.56 - $165.75
Beta: 0.80
52wk. High: $280.62
52wk. Low: $142.02
Ytd. Change -20.76%
50 Day Moving Average: $187.16
200 Day Moving Average: $209.82
Shares Outstanding: 97005674

Valuation

Market Cap: 1.6T
PE Ratio: -9.95
EPS (TTM): -16.61

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A